Dr. Mary Walton
Type 1 diabetes is a rigorous chronic illness that carries a heavy mental and emotional burden and requires ongoing vigilance. This article reviews the technological advances in type 1 diabetes treatment and management and examines the associated benefits. Over the past decade, developments in glucose monitoring systems, improved blood glucose monitoring meters, continuous glucose monitors, insulin delivery modalities, continuous subcutaneous insulin infusions, and closed-loop insulin delivery systems have allowed patients greater control over their disease state. These advancements lead to lower hemoglobin A1c and reduced hyper and hypoglycemic periods, thus achieving tighter glycemic control and improved quality of life. The advances in CGM and closed-looped systems have increased the quality of life, decreased disease burden, and eased care coordination between providers and patients. These outcomes lower the frequency of both short- and long-term complications. The future of continued merging of technology and chronic illness management continues to trailblaze patient experiences.
Skvarca C. Technological Advances in Type 1 Diabetes Management. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2023; 5(1).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.